Thrivent Financial For Lutherans Vir Biotechnology, Inc. Transaction History
Thrivent Financial For Lutherans
- $52.6 Billion
- Q3 2024
A detailed history of Thrivent Financial For Lutherans transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 71,892 shares of VIR stock, worth $707,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,892
Previous 72,287
0.55%
Holding current value
$707,417
Previous $643,000
16.33%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VIR
# of Institutions
215Shares Held
85.8MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$164 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$162 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$129 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$55.4 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$35.2 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.31B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...